Bruce Allen Runyon MDSpecial Hepatology Consultant to the Indian Health Service, Shiprock, New Mexico; Fellow of the Royal Society of Medicine; Fellow of the American Association for the Study of Liver Diseases
Bruce A. Runyon, M.D. is a Retired Clinical Professor of Medicine and Director of Hepatology at Santa Monica/UCLA. He has published 111 peer-reviewed articles (almost entirely focused on ascites), 46 textbook chapters, and 16 contributions to UpToDate. He was asked to contribute to UpToDate since its inception in 1996 and was selected to be Section Editor for Complications of Cirrhosis for UpToDate in 2006. His authored/edited topics were “hit” 4.3 million times in a year at the most recent count.
He has been elected to Best Doctors in America 2003-2014. He was elected into the American Society of Clinical Investigation. He was elected into America’s Top Physicians as well as America’s Top Gastroenterologists 2008-2011. In 2008 he was also elected by the Loma Linda University Medical Center Internal Medicine Residents as Attending of the Year and at UCLA received the Red Apple Faculty Teaching Award.
He was the first investigator to be asked to write a practice guideline for the American Association for the Study of Liver Diseases and the last author to write a single-author guideline, the furth guideline on ascites. Of his 489 worldwide presentations 52 have been at National Medical Education Courses, usually Digestive Disease Week and the American Association for the Study of Liver Diseases Course and Meeting. The American Board of Internal Medicine just created a new Certificate of Advanced Qualification for Transplant Hepatology. Dr Runyon was one of 24 Hepatologists in the US to be honored to lecture at the American Association for the Study of Liver Diseases’ first course (September 16-17, 2006) designed to prepare candidates to take the first examination for this Certificate.
Dr Runyon became interested in complications of cirrhosis, in particular ascites and ascitic fluid analysis in 1976 and has maintained these interests during his entire career. He is using his 15,600 microtube biobank in an active research project at the University of Southern California. Most of the results of his studies can be immediately applied to patient care to improve diagnostic accuracy and survival of patients with cirrhosis and ascites.